Introduction: Cancer is one of the main causes of death among adolescents and young adults (AYAs) aged 15–39 years. The improvement in overall 5-year survival in AYA cancer patients was far below than that of adult cancer patients. The purpose of this study was to clarify the features of cancer in AYAs by comparing them with those of controls. Methods: Patients in the cancer registry of the University of Tsukuba Hospital between 2007 and 2017 (median age, 65 years) were included in this study. We used patients between the ages of 64 and 66 years as controls. We then obtained the age at diagnosis, sex, primary site, and pathological type. Results: Among 27,281 cancer patients in the registry between 2007 and 2017, 1,947 (7.1%) patients were categorized into the AYA group, and 2,354 into the control group. Among men in the AYA group, central nervous system (CNS) tumors accounted for 22.7% of all cancers, followed by germ cell tumors, 22.5%, and hematopoietic malignancies, 12.5%. Among women in the AYA group, cervical cancer accounted for 35.9% of all cancers, followed by breast cancer, 14.6%, and CNS tumors, 11.6%. The proportion of specific cancer types relative to all cancers in the CNS, thyroid, adrenal glands, germ cells, cervix uteri, hematopoietic tissues, and sarcomas was higher in the AYA group than that in the control group. Conclusion: The present results for AYAs were in sharp contrast to those for adult cancers and may be related to different modes of pathogenesis in AYAs. The identification of high-risk groups of these tumors in the AYA generation is crucial for prevention and early detection and will be a major topic for future research. While most of adult cancers are treated independently by each medical department, AYA cancers need to be treated in collaboration with experts from several departments. It is desirable to address the issues involved in applying treatments established for adult cancers to AYA cancers on a cancer-by-cancer basis.

1.
Cancer Information Service, National Cancer Center, Japan
.
Cancer incidence NCR (2016–2017) (Ministry of Health, Labour and Welfare, National Cancer Registry). cancer registry and statistics
.
2017
. Available from: https://ganjoho.jp/reg_stat/statistics/dl/index.html (date last accessed: May 24, 2021).
2.
Director-General for Statistics and Information Policy, Ministry of Health, Labour and Welfare
.
Vital statistics of Japan
.
2019
. Available from: https://www.e-stat.go.jp/en/stat-search/files?page=1&toukei=00450011&tstat=000001028897 (date last accessed: May 24, 2021).
3.
Cancer Information Service National Cancer Center, Japan
.
Cancer mortality (1958–2019) (Vital statistics of Japan). Cancer registry and statistics
.
2019
. Available from: https://ganjoho.jp/reg_stat/statistics/dl/index.html (date last accessed: May 24, 2021).
4.
Bleyer
A
,
Ferrari
A
,
Whelan
J
,
Barr
R
.
Adolescents and young adults with cancer
. 11th ed. In:
DevitaJr
VT
,
Lawrence
TS
,
Rosenberg
SA
, editors.
Cancer: principles & practice of oncology
.
Philadelphia
:
Wolters Kluwer
;
2019
. p.
1617
31
.
5.
Adolescent and Young Adult Oncology Progress Review Group (2006)
.
Closing the gap: research and cancer care imperatives for adolescents and young adults with cancer
.
2006
. Available from: https://www.cancer.gov/types/aya/research/ayao-august-2006.pdf (date last accessed: May 24, 2021).
6.
Kanda
Y
.
Investigation of the freely available easy-to-use software “EZR” for medical statistics
.
Bone Marrow Transplant
.
2013
;
48
:
452
8
. .
7.
International Agency for Research on Cancer
.
Global cancer observatory: cancer today
. Available from: https://gco.iarc.fr/ (date last accessed: October 9, 2021).
8.
Oosterhuis
JW
,
Looijenga
LHJ
.
Human germ cell tumours from a developmental perspective
.
Nat Rev Cancer
.
2019
;
19
:
522
37
. .
9.
Mamsen
LS
,
Brøchner
CB
,
Byskov
AG
,
Møllgard
K
.
The migration and loss of human primordial germ stem cells from the hind gut epithelium towards the gonadal ridge
.
Int J Dev Biol
.
2012
;
56
:
771
8
. .
10.
Schneider
DT
,
Zahn
S
,
Sievers
S
,
Alemazkour
K
,
Reifenberger
G
,
Wiestler
OD
,
Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization
.
Mod Pathol
.
2006
;
19
:
864
73
. .
11.
Fukushima
S
,
Yamashita
S
,
Kobayashi
H
,
Takami
H
,
Fukuoka
K
,
Nakamura
R
,
Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas
.
Acta Neuropathol
.
2017
;
133
:
445
62
.
12.
Killian
JK
,
Dorssers
LC
,
Trabert
B
,
Gillis
AJ
,
Cook
MB
,
Wang
Y
,
Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors
.
Genome Res
.
2016
;
26
:
1490
504
.
13.
de Jong
J
,
Stoop
H
,
Gillis
AJ
,
van Gurp
RJ
,
van de Geijn
GJ
,
Boer
MD
,
Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications
.
J Pathol
.
2008
;
215
:
21
30
.
14.
Li
Y
,
Tabatabai
ZL
,
Lee
TL
,
Hatakeyama
S
,
Ohyama
C
,
Chan
WY
,
The Y-encoded TSPY protein: a significant marker potentially plays a role in the pathogenesis of testicular germ cell tumors
.
Hum Pathol
.
2007
;
38
:
1470
81
.
15.
Li
Y
,
Vilain
E
,
Conte
F
,
Rajpert-De Meyts
E
,
Lau
YF
.
Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ
.
Urol Oncol
.
2007
;
25
:
141
6
. .
16.
Hoei-Hansen
CE
,
Sehested
A
,
Juhler
M
,
Lau
YF
,
Skakkebaek
NE
,
Laursen
H
,
New evidence for the origin of intracranial germ cell tumours from primordial germ cells: expression of pluripotency and cell differentiation markers
.
J Pathol
.
2006
;
209
:
25
33
.
17.
Scheurer
ME
,
Lupo
PJ
,
Bondy
ML
.
Epidemiology of childhood cancer
. 7th ed. In:
Pizzo
PA
,
Poplack
DG
, editors.
Principles and practice of pediatric oncology
.
Philadelphia
:
Wolters Kluwer
;
2016
. p.
1
12
.
18.
Creutzig
U
,
Matthew Kutny
M
,
Schelenk
RF
.
Acute myelogenous leukemia
. 2nd ed. In:
Bleyer
A
,
Barr
R
,
Ries
L
,
Whelan
J
,
Ferrari
A
, editors.
Cancer in adolescents and young adults
.
Cham
:
Springer International Publishing AG
;
2017
. p.
135
49
.
19.
Lee
KM
,
Ward
MH
,
Han
S
,
Ahn
HS
,
Kang
HJ
,
Choi
HS
,
Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk
.
Leuk Res
.
2009
;
33
:
250
8
.
20.
Castle
PE
,
Fetterman
B
,
Akhtar
I
,
Husain
M
,
Gold
MA
,
Guido
R
,
Age-appropriate use of human papillomavirus vaccines in the U.S
.
Gynecol Oncol
.
2009
;
114
:
365
9
.
21.
Skrzynski
MC
,
Biermann
JS
,
Montag
A
,
Simon
MA
.
Diagnostic accuracy and charge-savings of outpatient core needle biopsy compared with open biopsy of musculoskeletal tumors
.
J Bone Joint Surg Am
.
1996
;
78
:
644
9
. .
22.
Luoh
SW
,
Flaherty
KT
.
When tissue is no longer the issue: tissue-agnostic cancer therapy comes of age
.
Ann Intern Med
.
2018
;
169
:
233
9
. .
23.
Pestana
RC
,
Sen
S
,
Hobbs
BP
,
Hong
DS
.
Histology-agnostic drug development: considering issues beyond the tissue
.
Nat Rev Clin Oncol
.
2020
;
17
:
555
68
. .
24.
Walker
D
,
Bendel
A
,
Stiller
C
,
Indelicato
D
,
Smith
S
,
Murray
M
,
Central nervous system tumors
. 2nd ed. In:
Bleyer
A
,
Barr
R
,
Ries
L
,
Whelan
J
,
Ferrari
A
, editors.
Cancer in adolescents and young adults
.
Cham
:
Springer International Publishing AG
;
2017
. p.
335
81
. .
25.
Ferrari
A
,
Patel
SR
,
Wunder
J
,
Albritton
KH
.
Soft tissue sarcoma
. 2nd ed. In:
Bleyer
A
,
Barr
R
,
Ries
L
,
Whelan
J
,
Ferrari
A
, editors.
Cancer in adolescents and young adults
.
Cham
:
Springer International Publishing AG
;
2017
. p.
383
416
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.